Key result
Cardiometabolic risk factors and female-specific enhancers pose greater cardiovascular risk to women than men.
Why the study?
Increasing evidence indicates sex-specific differences in patient-related, drug-related, and socio-demographic factors lead to suboptimal care of women, motivating discussion of cardiometabolic risk factors affecting women.
This review highlights that women face unique and more adverse impacts from common cardiometabolic risk factors, as well as female-specific risk enhancers like premature menopause and PCOS.
Answers are grounded in this paper and cite their sources.
May warrant closer cardiometabolic monitoring in women with PCOS or premature menopause; leaves open need for prospective validation.
PURPOSE OF REVIEW: The aim of this review was to discuss cardiometabolic risk factors that affect women. RECENT FINDINGS: Recent calls to action to address cardiometabolic risk factors specific to women relate to increasing evidence of sex-specific differences in patient-related, drug-related, and socio-demographic factors leading to sub-optimal care of women. SUMMARY: Certain aspects of common modifiable cardiovascular risk factors (e.g. smoking, hypertension, dyslipidaemia and diabetes) affect female individuals more adversely. Additionally, there are risk factors or enhancers that particularly affect cardiometabolic health in women [e.g. premature menopause, polycystic ovarian syndrome (PCOS), familial partial lipodystrophy, socio-cultural factors]. Understanding these risk factors may provide insight on how to improve cardiometabolic outcomes in women.
No takes yet. Share an insight, caveat, or question.
Loh et al. (2024) conducted a review in Cardiometabolic risk factors. Cardiometabolic risk factors such as smoking, hypertension, and diabetes, along with female-specific enhancers like premature menopause and PCOS, affect women more adversely than men.
Synapse has enriched 10 related papers. Consider them for comparative context: